Vorsetuzumab mafodotin
Vorsetuzumab mafodotin Uses, Dosage, Side Effects, Food Interaction and all others data.
Vorsetuzumab mafodotin is under investigation in clinical trial NCT01677390 (A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma).
| Trade Name | Vorsetuzumab mafodotin |
| Generic | Vorsetuzumab mafodotin |
| Vorsetuzumab mafodotin Other Names | Vorsetuzumab mafodotin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Vorsetuzumab mafodotin
